Genmab Files Annual Report with the U.S. Securities and Exchange Commission
17/2 17:23
Media Release COPENHAGEN, Denmark; February 17, 2026 Genmab filed Form 20-F for the financial year 2025 with the U.S. SEC Genmab A/S (Nasdaq: GMAB) a nnounced today that it has filed its Annual Report for the financial year 2025 on Form 20-F with the U.S....